This study reports on the outcome of four patients having ileal pouch anal anastomosis after orthotopic liver transplantation for sclerosing cholangitis complicating ulcerative colitis. There were no deaths on follow up. Early postoperative bleeding was a complication of colectomy or rectal excision in three, one of whom developed hepatic artery thrombosis and the overall complication rate was high. All patients are continent but one has chronic pouchitis (while receiving longterm metronidazole) and one patient has recurrent sclerosing cholangitis in the transplant.
with the intention of including a synchronous ileopouch anal anastomosis but this was considered too hazardous in the face ofportal hypertension. He subsequently developed bleeding oesophageal varices (1990) and deteriorating liver function requiring orthotopic liver transplantation (1991) and Roux biliary reconstruction. Postoperative immunosuppression was initially with prednisolone, azathioprine, and cyclosporin A but was subsequently maintained with cyclosporin A alone. Continued bloody discharge from the rectal stump led to rectal excision and ileopouch anal anastomosis (1993) with covering ileostomy but this was complicated by pelvic haematoma, which was drained percutaneously under ultrasound control. The loop ileostomy was closed in January 1994, liver function tests remain normal, and he is continent with a bowel frequency of five to seven stools per 24 hours.
The Table shows the results of ileopouch anal anastomosis after orthotopic liver transplantation.
Discussion
Definitive surgery for ulcerative colitis in the presence of sclerosing cholangitis has been reported previously in patients without orthotopic liver transplantation but this is the first report of patients treated by ileopouch anal anastomosis for underlying ulcerative colitis after liver transplantation. Post-transplant colectomy is an uncommon scenario as the colonic disease, if it needs treatment at all, is usually resected before the liver disease. Sclerosing cholangitis is now the third most common cause for liver transplantation both in our series and in others. ' both for symptomatic relapse and for cancer prophylaxis in the immunosuppressed patients.
Since the introduction of ileopouch anal anastomosis4 this surgical option has been gaining increasing acceptance and is now considered by many to be the treatment of choice for young, well motivated patients undergoing colectomy for ulcerative colitis. More than 90% of patients can expect an almost normal quality of life after ileopouch anal anastomosis,5 whereas frequent problems can be expected after colectomy and Brooke ileostomy with a re-intervention rate of 67o/o. 6 In our previous report of non-transplanted patients, postoperative haemorrhage was found to be uncommon after ileopouch anal anastomosis, being recorded in only four of 168 cases.7 Bleeding is a recognised problem, however, in patients having definitive surgery for ulcerative colitis in the presence of sclerosing cholangitis without transplantation.3 Furthermore, this experience shows that bleeding was encountered in three of four cases, thus definitive surgery in the post-transplant patient calls for special vigilance.
All four patients had a Roux biliary reconstruction to avoid using a diseased native bile duct. This is a theoretical disadvantage in that during formation of the J pouch there may be insufficient length in the small bowel mesentry to achieve a tension free anastomosis but we did not find this to be a problem. Furthermore, it was possible to construct a covering loop ileostomy to protect the anastomosis and minimise the consequences of pelvic sepsis in these immunosuppressed patients because we know that pelvic sepsis may compromise pouch function. 8 Pouchitis, which is reported in between 
